After publication of this work [1], the authors noticed that the first names and last names of all the authors were inverted. In the original manuscript, they appear on PubMed as.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107953 | PMC |
| http://dx.doi.org/10.1186/s13000-018-0723-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization.
Sci Rep
January 2025
First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), decreases quality of life and causes disability. The underlying processes are not fully understood. This study uses Mendelian randomization (MR) analysis to identify cytokines that may be associated with UC and CD, aiding in early diagnosis and treatment decisions.
View Article and Find Full Text PDFGreater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn's Disease.
Crohns Colitis 360
January 2025
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Article Synopsis
- The study explored the link between Crohn's disease activity, fatigue, and neurocognitive function in adults, comparing 25 patients with Crohn's to 26 healthy controls.
- Patients with Crohn's disease reported significantly higher levels of fatigue, particularly when symptomatic, but showed no differences in neurocognitive accuracy or speed compared to healthy individuals.
- However, those with active Crohn's disease had slower response times in social cognition and episodic memory tasks, indicating a relationship between disease activity and cognitive processing, regardless of fatigue levels.
Correction to: Amino acid-based enteral nutrition is effective for pediatric Crohn's disease: a multicenter prospective study.
Gastroenterol Rep (Oxf)
December 2024
[This corrects the article DOI: 10.1093/gastro/goad072.].
View Article and Find Full Text PDFProvider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease.
Inflamm Bowel Dis
November 2024
RMEI, Medical Education, Voorhees, NJ, USA.
Background: Despite the growing availability of advanced medical therapies for inflammatory bowel disease (IBD), significant gaps remain in treatment initiation. Targeted education and point-of-care clinical decision support may address this gap and lead to improved patient outcomes.
Methods: A multiphase IBD-focused provider education and decision support program spanning 10 years was developed consisting of (1) symposia-based education (n = 1101 learners; 2014 to 2019), (2) point-of-care education (n = 8547 learners) with clinical decision support tool (CDST) deployment (n = 11 940 users, n = 954 learners; 2019 to 2023), and (3) data-driven platform optimization (2024).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!